Your browser doesn't support javascript.
loading
Paracrine signalling by cardiac calcitonin controls atrial fibrogenesis and arrhythmia.
Moreira, Lucia M; Takawale, Abhijit; Hulsurkar, Mohit; Menassa, David A; Antanaviciute, Agne; Lahiri, Satadru K; Mehta, Neelam; Evans, Neil; Psarros, Constantinos; Robinson, Paul; Sparrow, Alexander J; Gillis, Marc-Antoine; Ashley, Neil; Naud, Patrice; Barallobre-Barreiro, Javier; Theofilatos, Konstantinos; Lee, Angela; Norris, Mary; Clarke, Michele V; Russell, Patricia K; Casadei, Barbara; Bhattacharya, Shoumo; Zajac, Jeffrey D; Davey, Rachel A; Sirois, Martin; Mead, Adam; Simmons, Alison; Mayr, Manuel; Sayeed, Rana; Krasopoulos, George; Redwood, Charles; Channon, Keith M; Tardif, Jean-Claude; Wehrens, Xander H T; Nattel, Stanley; Reilly, Svetlana.
Afiliação
  • Moreira LM; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Takawale A; Research Centre, Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada.
  • Hulsurkar M; Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.
  • Menassa DA; Cardiovascular Research Institute, Baylor College of Medicine, Houston, TX, USA.
  • Antanaviciute A; Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX, USA.
  • Lahiri SK; Clinical Neurology, Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Mehta N; Biological Sciences, Faculty of Life and Environmental Sciences, University of Southampton, Southampton, UK.
  • Evans N; Medical Research Council (MRC) Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Psarros C; Cardiovascular Research Institute, Baylor College of Medicine, Houston, TX, USA.
  • Robinson P; Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX, USA.
  • Sparrow AJ; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Gillis MA; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Ashley N; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Naud P; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Barallobre-Barreiro J; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Theofilatos K; Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.
  • Lee A; Department of Pharmacology and Physiology, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.
  • Norris M; Single-Cell Genomics Facility, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Clarke MV; Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.
  • Russell PK; Department of Pharmacology and Physiology, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.
  • Casadei B; King's British Heart Foundation Centre, King's College London, London, UK.
  • Bhattacharya S; King's British Heart Foundation Centre, King's College London, London, UK.
  • Zajac JD; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Davey RA; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Sirois M; Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia.
  • Mead A; Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia.
  • Simmons A; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Mayr M; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Sayeed R; Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia.
  • Krasopoulos G; Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia.
  • Redwood C; Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.
  • Channon KM; Department of Pharmacology and Physiology, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.
  • Tardif JC; Medical Research Council (MRC) Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Wehrens XHT; Medical Research Council (MRC) Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Nattel S; King's British Heart Foundation Centre, King's College London, London, UK.
  • Reilly S; Cardiothoracic Surgery, Oxford Heart Centre, John Radcliffe Hospital, Oxford, UK.
Nature ; 587(7834): 460-465, 2020 11.
Article em En | MEDLINE | ID: mdl-33149301
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Arritmias Cardíacas / Fibrinogênio / Calcitonina / Comunicação Parácrina / Átrios do Coração / Miocárdio Limite: Animals / Female / Humans / Male Idioma: En Revista: Nature Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Arritmias Cardíacas / Fibrinogênio / Calcitonina / Comunicação Parácrina / Átrios do Coração / Miocárdio Limite: Animals / Female / Humans / Male Idioma: En Revista: Nature Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido